The Value of Glioma Extent of Resection in the Modern Neurosurgical Era

Objective: There remains no general consensus in the neurosurgical oncology literature regarding the role of extent of glioma resection in improving patient outcome. Although the value of resection in establishing a diagnosis and alleviating mass effect is clear, there is less certainty in ascertaining the influence of extent of resection (EOR). Here, we review the recent literature to synthesize a comprehensive review of the value of extent of resection for gliomas in the modern neurosurgical era. Methods: We reviewed every major peer-reviewed clinical publication since 1990 on the role of EOR in glioma outcome. Results: Thirty-two high-grade glioma articles and 11 low-grade glioma articles were examined in terms of quality of evidence, expected EOR, and survival benefit. Conclusion: Despite limitations in the quality of data, mounting evidence suggests that more extensive surgical resection is associated with longer life expectancy for both low- and high-grade newly diagnosed gliomas.

[1]  Kiyoshi Sato,et al.  Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas , 1995, Cancer.

[2]  B. Scheithauer,et al.  A phase III study of radiation therapy plus carmustine with or without recombinant interferon‐α in the treatment of patients with newly diagnosed high‐grade glioma , 2001 .

[3]  B. Scheithauer,et al.  Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Lui,et al.  Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. , 2005, The British journal of radiology.

[5]  C. Avezaat,et al.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[6]  K. Takakura,et al.  Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. , 1997, Neurosurgery.

[7]  Hideo Nakamura,et al.  Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. , 2005, Neurologia medico-chirurgica.

[8]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Mitchel S Berger,et al.  An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.

[10]  A. Karim The management of histologically unverified presumed cerebral gliomas with radiotherapy. , 1995, International journal of radiation oncology, biology, physics.

[11]  T. Kumabe,et al.  Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases. , 2007, Journal of neurosurgery.

[12]  Jörg-Christian Tonn,et al.  Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. , 2011, Journal of neurosurgery.

[13]  R. Arusell,et al.  A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival , 2005, Neurosurgery.

[14]  L. Salford,et al.  A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4 , 1991, Cancer.

[15]  A. Becherer,et al.  Supratentorielle Gliome: Analyse klinischer und zeitlicher Parameter in 163 Fällen , 1993 .

[16]  M. Prados,et al.  Anaplastic Oligodendrogliomas: Prognostic Factors for Tumor Recurrence and Survival , 2003, Oncology.

[17]  M. Prados,et al.  Radiation response and survival time in patients with glioblastoma multiforme. , 1996, Journal of neurosurgery.

[18]  P. Warnke,et al.  Response to Drs. Simpson, et al.: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group clinical trials. , 1994, International journal of radiation oncology, biology, physics.

[19]  Y. Shibamoto,et al.  Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  D. Nelson,et al.  Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. , 1993, International journal of radiation oncology, biology, physics.

[21]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[22]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[23]  Neurochirurgische Klinik,et al.  Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study , 2011 .

[24]  F. Langmark,et al.  Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. , 2003, Journal of neurosurgery.

[25]  J. Acebes,et al.  Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas , 2003, Cancer.

[26]  Veit Rohde,et al.  EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.

[27]  O. Witte,et al.  Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. , 1997, Neurosurgery.

[28]  W. Yung,et al.  Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. , 2002, International journal of radiation oncology, biology, physics.

[29]  Pieter L Kubben,et al.  Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. , 2011, The Lancet. Oncology.

[30]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[31]  H. Höllerhage,et al.  Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme , 2005, Acta Neurochirurgica.

[32]  M. Berger,et al.  Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Yuta Shibamoto,et al.  Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach , 2005, Journal of Neuro-Oncology.

[34]  H. Mehdorn,et al.  Glioblastoma multiforme-report of 267 cases treated at a single institution. , 2005, Surgical neurology.

[35]  K. Franz,et al.  Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. , 2012, Journal of neurosurgery.

[36]  B. Scheithauer,et al.  A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. , 2001, Cancer.

[37]  Mitsutoshi Nakamura,et al.  Analysis of Prognostic and Survival Factors Related to Treatment of Low-Grade Astrocytomas in Adults , 2000, Oncology.

[38]  Mitchel S. Berger,et al.  Operative techniques for gliomas and the value of extent of resection , 2009, Neurotherapeutics.

[39]  Tarik Tihan,et al.  Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. , 2006, Journal of neurosurgery.

[40]  Susan M. Chang,et al.  Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. , 2004, Neuro-oncology.

[41]  Paul S Mischel,et al.  MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.

[42]  R. Arusell,et al.  Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas , 2006, Journal of Neuro-Oncology.

[43]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.

[44]  A. Jakola,et al.  The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. , 2011, World neurosurgery.

[45]  W. Powlis,et al.  Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials , 1992, Journal of Neuro-Oncology.

[46]  F. Jolesz,et al.  Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance , 2005, Cancer.

[47]  C. Avezaat,et al.  Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery , 1998, Journal of neurology, neurosurgery, and psychiatry.

[48]  R. Arusell,et al.  A Prospective Study of Quality of Life in Adults With Newly Diagnosed High-Grade Gliomas: Comparison of Patient and Caregiver Ratings of Quality of Life , 2008, American journal of clinical oncology.

[49]  J H Philippon,et al.  Supratentorial low-grade astrocytomas in adults. , 1993, Neurosurgery.

[50]  Susan M. Chang,et al.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Mitchel S. Berger,et al.  Intraoperative stimulation techniques for functional pathway preservation and glioma resection. , 2010, Neurosurgical focus.

[52]  Alfredo Quinones-Hinojosa,et al.  ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.

[53]  M. Berger,et al.  The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. , 1999, Surgical neurology.

[54]  B. Scheithauer,et al.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  M. Prados,et al.  Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. , 1991, International journal of radiation oncology, biology, physics.

[56]  M. Prados,et al.  Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. , 1992, International journal of radiation oncology, biology, physics.